Company news
electroCore, Inc. news in 2022
electroCore, Inc.'s news releases, calls and decks from 2022, newest first.
electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga™
December 19, 2022
electroCore Announces Issuance of Two New U.S. Patents
December 6, 2022
gammaCore Sapphire™ Non-Invasive Vagus Nerve Stimulator (nVNS) Receives Unique National Product Code Number by the Belgian Pharmaceutical Association
November 17, 2022
electroCore Announces Third Quarter 2022 Financial Results
November 2, 2022
electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC
October 31, 2022
electroCore and Joerns Healthcare Partner to Expand Use Of gammaCore™ Vagus Nerve Technology for Headache Sufferers
October 31, 2022
electroCore to Announce Third Quarter 2022 Financial Results on November 3
October 26, 2022
electroCore Provides Select Third Quarter 2022 Financial Guidance
October 13, 2022
electroCore Strengthens Patent Portfolio with Issuance of Four New U.S. Patents
September 20, 2022
Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
September 19, 2022
electroCore Announces Record Second Quarter 2022 Financial Results
August 3, 2022
electroCore to Announce Second Quarter 2022 Financial Results on August 4
July 27, 2022
electroCore Provides Select Second Quarter 2022 Financial Guidance
July 11, 2022
electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome
July 6, 2022
electroCore Announces Listing Transfer to the Nasdaq Capital Market
June 22, 2022
electroCore, Inc. Announces gammaCore™ Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers
May 23, 2022
electroCore Announces Record First Quarter 2022 Financial Results
May 4, 2022
electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology
April 20, 2022
electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance
April 11, 2022
electroCore Announces Exclusive License Agreement with Teijin for Japan Territory
April 4, 2022
electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York
March 22, 2022
electroCore Announces Fourth Quarter and Full Year 2021 Financial Results
March 9, 2022
electroCore Announces Changes to its Board of Directors
March 8, 2022
electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus
January 31, 2022
electroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022
January 24, 2022
electroCore Announces Shareholder Letter and Full-Year 2021 Business Update
January 17, 2022
gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
January 11, 2022
electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store
January 10, 2022
electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine
January 9, 2022